Evidence mapPaperPMID 18826999Full record

Trial reportThe Journal of clinical endocrinology and metabolism2008

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

Robert E Ratner, Costas A Christophi, Boyd E Metzger, Dana Dabelea, Peter H Bennett, Xavier Pi-Sunyer, Sarah Fowler, Steven E Kahn, Diabetes Prevention Program Research Group

4 registry-linked trialsOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 384 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
384citing papers in PubMed, 16 pooled it
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05280496 phase3completedstarted 2022, after this paper: background citation

Implementation of a Pragmatic Approach to Lower Diabetes Mellitus Risk After a Diagnosis of Gestational Diabetes Mellitus

Ran2022Enrolled20Registered outcomes4Posted comparisons0ConditionsDiabetes, Gestational, Diabetes Mellitus, Type 2, PrediabetesArmsMetformin
Open the trial in the graph
NCT06064669 narecruitingstarted 2024, after this paper: background citation

Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial

Ran2024Enrolled988Registered outcomes26Posted comparisons0ConditionsIn-Vitro Fertilization, Metformin, PrediabetesArmsMetformin pretreatment before endometrial preparation for frozen embryo transfer, Metformin pretreatment before ovarian stimulation, Placebo pretreatment before endometrial preparation for frozen embryo transfer, Placebo pretreatment before ovarian stimulation
Open the trial in the graph
NCT03997773 nacompletednot on this mapstarted 2019, after this paper: background citation

Face-it: A Health Promotion Intervention for Women With Prior Gestational Diabetes and Their Families - A Randomised Controlled Trial

TypeinterventionalSponsorSteno Diabetes Center CopenhagenRan2019 to 2023Enrolled277ConditionsGestational Diabetes, Type 2 Diabetes Mellitus, Quality of LifeArmsFace-it Intervention
NCT06457139 nacompletednot on this mapstarted 2025, after this paper: background citation

Preventing Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus With Immediate Postpartum Screening

TypeinterventionalSponsorUniversity of Massachusetts, WorcesterRan2025 to 2026Enrolled116ConditionsGestational Diabetes, Type 2 DiabetesArmsGlucose tolerance test (2 hour), Active Comparator
3 · Its place in the literature

Who cites it

384 citing papers in PubMed, 16 syntheses or guidelines pooled it, 863 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Trial
  19. Trial
  20. Trial

324 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Robert E RatnerMedstar Research Institute, Hyattsville, Maryland 20783, USA.
Costas A Christophi
Boyd E Metzger
Dana Dabelea
Peter H Bennett
Xavier Pi-Sunyer
Sarah Fowler
Steven E Kahn
Diabetes Prevention Program Research Group
George Washington University · USMedStar Union Memorial Hospital · USNational Institutes of Health · USSt. Luke's-Roosevelt Hospital Center · USUniversity of Colorado Denver · USUniversity of Washington · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

contextA past history of gestational diabetes mellitus (GDM) confers a very high risk of postpartum development of diabetes, particularly type 2 diabetes.

objectiveThe Diabetes Prevention Program (DPP) sought to identify individuals with impaired glucose tolerance (IGT) and intervene in an effort to prevent or delay their progression to diabetes. This analysis examined the differences between women enrolled in DPP with and without a reported history of GDM.

designThe DPP was a randomized, controlled clinical trial.

settingThe study was a multicenter, National Institutes of Health-sponsored trial carried out at 27 centers including academic and Indian Health Services sites. PATIENTS: A total of 2190 women were randomized into the DPP and provided information for past history of GDM. This analysis addressed the differences between those 350 women providing a past history of GDM and those 1416 women with a previous live birth but no history of GDM.

interventionsSubjects were randomized to either standard lifestyle and placebo or metformin therapy or to an intensive lifestyle intervention. MAIN OUTCOMES: The primary outcome was the time to development of diabetes ascertained by semiannual fasting plasma glucose and annual oral glucose tolerance testing. Assessments of insulin secretion and insulin sensitivity were also performed.

resultsWhereas entering the study with similar glucose levels, women with a history of GDM randomized to placebo had a crude incidence rate of diabetes 71% higher than that of women without such a history. Among women reporting a history of GDM, both intensive lifestyle and metformin therapy reduced the incidence of diabetes by approximately 50% compared with the placebo group, whereas this reduction was 49 and 14%, respectively in parous women without GDM. These data suggest that metformin may be more effective in women with a GDM history as compared with those without.

conclusionsProgression to diabetes is more common in women with a history of GDM compared with those without GDM history despite equivalent degrees of IGT at baseline. Both intensive lifestyle and metformin are highly effective in delaying or preventing diabetes in women with IGT and a history of GDM.

Indexed as

Life StyleAdultCardiovascular DiseasesDiabetes, GestationalDiabetes MellitusDouble-Blind MethodFemaleGlucose IntoleranceHumansHypoglycemic AgentsMetforminMotor ActivityPregnancyProportional Hazards ModelsRisk FactorsHypoglycemic AgentsMetformin

Identifiers

PMID18826999
PMCPMC2626441
OpenAlexW2166996912

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.